What it is
Policosanol is a mixture of long-chain aliphatic alcohols (primarily octacosanol, triacontanol, and hexacosanol) extracted from sugar cane wax or beeswax. It was developed in Cuba and extensively studied by Cuban research groups.
Supplement · Cholesterol Support
Policosanol
sugar-cane wax alcohols · octacosanol · triacontanol · Polycosanol
10 mg · vegan · gluten-free · 150 caps
high cholesterolelevated LDLpoor lipid profile liverheart
Affiliate link · we earn from qualifying purchases. No paid placements.
How it works
The proposed mechanism involves inhibition of cholesterol synthesis in the liver and increased LDL receptor activity. Octacosanol may also improve nerve conduction and exercise performance through mitochondrial effects.
Who should take it
Adults with mild cholesterol elevation, individuals interested in sugar cane-derived supplements, those seeking alternatives to statins (with appropriate expectations).
Avoid / careful
People taking anticoagulants (potential interaction), those with bleeding disorders, pregnant or breastfeeding women, children.
Build your stack
Pick a depth — minimum to maximal coverage
One
If you pick just one
1 supplement
Policosanol
MES
Minimum effective stack
4 supplements
Red Yeast RicePlant SterolsOmega-3Bergamot
Full stack
No full stack configured.
Click individual supplement pills above to buy each on Amazon India.
When to take it
Morning
Noon
Evening
✓ Evening aligns with peak cholesterol synthesis
Night
How to take it
With food
✓ Food improves absorption of lipid-soluble alcohols
Empty stomach
Before food
FAQs
Frequently asked
How long until Policosanol starts working?
Most supplements show effects in 2-8 weeks of consistent daily use. Notable effects from Policosanol typically appear within this window, though individual response varies based on baseline status, dose, and underlying biochemistry.
When should I take Policosanol?
Policosanol works best taken evening, ideally with food. Typical dose: 5–20 mg daily. Consistency over time matters more than perfect timing.
Is Policosanol safe to take long-term?
For most adults, yes — with the cautions noted: People taking anticoagulants (potential interaction), those with bleeding disorders, pregnant or breastfeeding women, children.. Periodic breaks (1-2 weeks every 8-12 weeks) are reasonable for any chronic supplementation.
Is Policosanol vegan and vegetarian-friendly?
Yes — Policosanol is vegan and vegetarian-suitable. Look for capsules made from vegetable cellulose rather than gelatin for fully plant-based options.
Is Policosanol available in India and what should I look for when buying?
Policosanol is widely available on Amazon India and in supplement stores in major cities. Look for products standardised to active compounds where applicable — 10 mg is a typical serving. Himalaya, Organic India, and NOW Foods are among the brands available in India. Check for third-party testing certificates (NSF, USP, or Informed Sport) on the label. Imported brands tend to have stronger standardisation; Indian Ayurvedic brands are often more affordable for herbal forms.
Can pregnant or breastfeeding women take Policosanol?
No — Policosanol should be avoided during pregnancy and breastfeeding. People taking anticoagulants (potential interaction), those with bleeding disorders, pregnant or breastfeeding women, Always consult your obstetrician before starting any new supplement during pregnancy.
Research
3 studies · 2003 – 2006 · Trial sizes vary — see individual studies for sample sizes. 3
Studies reviewed
2003 – 2006
D
Evidence grade
see methodology note
20 mg
Notable effect size
JAMA 2006
3 RCTs
Cited evidence
PubMed-verified
Policosanol capsules and raw ingredient — laboratory quality standardised extract
real-life image
Clinical trial setting — high cholesterol measurement protocol
real-life image
Policosanol effect on high cholesterol — before/after comparison
real-life image
How it works
The proposed mechanism involves inhibition of cholesterol synthesis in the liver and increased LDL receptor activity.
Reported effects across cited trials
Each bar = one cited trial. Effect varies by methodology, dose, and population.
LDL-C trend across 12-week trial
Dyslipidaemia cohort (n≈75)
Target LDL <100 mg/dL for cardiovascular risk reduction.
Featured studies
Effect of policosanol on lipid levels among healthy volunteers
see study
→ NULL: 20 mg/day for 12 weeks did NOT change LDL, HDL, or triglycerides vs placebo (N=54)
Policosanol does not reduce LDL oxidation in healthy volunteers
see study
→ NULL: No effect on LDL oxidation, lipid levels, or inflammatory markers (N=75)
Policosanol is ineffective in treating hypercholesterolemia: a randomized controlled trial
see study
→ NULL: 10–20 mg/day for 12 weeks no different from placebo (N=67)
Evidence grade
ABCD
D · Multiple Western RCTs are NULL; Cuban data is positive but not independently replicated; significant geographic publication bias; not recommended as primary lipid therapy
In plain English
A plain-English read of the literature behind this supplement. Not a clinical recommendation.
Key citations: Abenavoli 2010 (hepatoprotection systematic review), Cacciapuoti 2013 (NAFLD RCT). richResearch section contains study filters.
From the blog
· 7 min read
Policosanol for high cholesterol: protocol, dose, and what to track
How to use Policosanol specifically for high cholesterol — the right dose, timing, blood markers to track, and how to know if it is working.
#cholesterol support#high-cholesterol#protocol
· 6 min read
Policosanol: what the research actually shows
A clinical evidence review of Policosanol — RCT data, effect sizes, evidence grade, and what the numbers mean for your specific situation.
#cholesterol support#research#evidence
· 8 min read
Policosanol: complete India guide
Everything you need to know about Policosanol — mechanism, dose, safety, buying guide for India, and what the research actually says.
#cholesterol support#guide#india
Editorial notes
SacredBod's longer take on Policosanol — context the structured blocks above don't capture.
Policosanol is the cautionary tale of supplement research. Developed in Cuba and extensively promoted by Cuban research groups, it was initially hailed as a natural cholesterol-lowering agent with statin-like efficacy but none of the side effects. The Cuban studies were impressive: LDL reductions of 15–25%, HDL increases of 10–15%, and minimal adverse effects. These results were published in peer-reviewed journals and replicated across multiple Cuban trials. The problem is that when independent researchers outside Cuba attempted replication, the results were uniformly null.
Berthold and colleagues (2006, JAMA, PMID 16461858) conducted a rigorous randomized placebo-controlled trial in 54 healthy German volunteers, testing 20 mg policosanol daily for 12 weeks. The result: no significant difference between policosanol and placebo for LDL, HDL, triglycerides, or total cholesterol. Every lipid parameter remained unchanged. This was not a flawed trial—it was well-powered, double-blind, and used the same dose that Cuban studies had found effective. Marinangeli and colleagues (2006, Atherosclerosis, PMID 17036072) extended this finding, testing 10 mg policosanol in 75 Canadian patients and finding no effect on lipid levels, LDL oxidation, or inflammatory markers. Varady and colleagues (2003, American Heart Journal, PMID 12878251) similarly found no effect at 10–20 mg in 67 hypercholesterolemic patients.
The geographic discrepancy is striking. All positive trials originate from Cuba or Cuban-affiliated researchers. All null trials come from North America or Europe. This pattern suggests publication bias, methodological differences, or genuine geographic variation in response (perhaps due to genetic or dietary factors). However, the null trials are methodologically sound and independently conducted, while the positive trials share authorship networks. The scientific consensus has shifted: policosanol is not an effective lipid-lowering agent in Western populations.
The honest framing is uncomfortable but necessary. Policosanol was marketed extensively based on Cuban data, and many consumers continue to purchase it believing the initial claims. The evidence does not support this use. The 2006 JAMA null result and subsequent replications have effectively closed the book on policosanol as a cholesterol treatment. It may have niche applications—octacosanol has been studied for exercise performance and nerve conduction—but the lipid-lowering claims are not supported by independent evidence.
Added to your stack.